The effects of moderate alcohol consumption on non-alcoholic fatty liver disease

키워드

참고문헌 (60)

1. Sheka AC, "Nonalcoholic steatohepatitis : a review", JAMA, 323, pp.1175~1183 (2020)
2. Cusi K, "American Association of Clinical Endocrinology Clinical Practice Guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings : Co-Sponsored by the American Association for the Study of Liver Diseases(AASLD)", Endocr Pract, 28, pp.528~562 (2022)
3. Lazarus JV, "Advancing the global public health agenda for NAFLD: a consensus statement", Nat Rev Gastroenterol Hepatol, 19, pp.60~78 (2022)
4. Michael H. Le, "Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach", Clinical and Molecular Hepatology, 28(4), pp.841~850 (2022), 대한간학회
5. Cheng Han Ng, "The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 28(3), pp.565~574 (2022), 대한간학회[DOI]
6. Paik JM, "The growing burden of disability related to chronic liver disease in the United States : data from the global burden of disease study 2007-2017", Hepatol Commun, 5, pp.749~759 (2021)
7. Jaejun Lee, "Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population- based cross-sectional study", Clinical and Molecular Hepatology, 28(2), pp.196~206 (2022), 대한간학회[DOI]
8. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67, pp.328~357 (2018)
9. European Association for the Study of the Liver(EASL), "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease", J Hepatol, 64, pp.1388~1402 (2016)
10. 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
11. Kenichi Ikejima, "Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights", Clinical and Molecular Hepatology, 26(4), pp.728~735 (2020), 대한간학회
12. Carlos J. Pirola, "Personalized medicine in nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 28(4), pp.935~938 (2022), 대한간학회
13. Silvia Sookoian, "Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response", Clinical and Molecular Hepatology, 29, pp.184~195 (2023), 대한간학회
14. Takumi Kawaguchi, "MAFLD enhances clinical practice for liver disease in the Asia-Pacific region", Clinical and Molecular Hepatology, 28(2), pp.150~163 (2022), 대한간학회[DOI]
15. Hwi Young Kim, "Recent advances in nonalcoholic fatty liver disease metabolomics", Clinical and Molecular Hepatology, 27(4), pp.553~559 (2021), 대한간학회[DOI]
16. Ntandja Wandji LC, "Combined alcoholic and non-alcoholic steatohepatitis", JHEP Rep, 2, pp.100101~ (2020)
17. Jong Hwa Choi, "The effect of moderate alcohol drinking in nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 26(4), pp.662~669 (2020), 대한간학회[DOI]
18. Inbeom Kwon, "Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease", Gut and Liver, 13(3), pp.308~314 (2019), 거트앤리버 소화기연관학회협의회[DOI]
19. "Drinking Levels Defined"[URL]
20. "International Guide for Monitoring Alcohol Consumption and Related Harm"[URL]
21. "Cirrhosis in over 16s: assessment and management"[URL]
22. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology", Gastroenterology, 142, pp.1592~1609 (2012)
23. Francque SM, "Non-alcoholic fatty liver disease : a patient guideline", JHEP Rep, 3, pp.100322~ (2021)
24. Wong VW, "Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1 : Definition, risk factors and assessment", J Gastroenterol Hepatol, 33, pp.70~85 (2018)
25. Fan JG, "Guidelines of prevention and treatment of nonalcoholic fatty liver disease(2018, China)", J Dig Dis, 20, pp.163~173 (2019)
26. Cao G, "Alcohol consumption and risk of fatty liver disease : a meta-analysis", PeerJ, 4, pp.e2633~ (2016)
27. Wijarnpreecha K, "Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease : a systematic review and meta-analysis", Ann Gastroenterol, 34, pp.568~574 (2021)
28. Sookoian S, "Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease : a metaanalysis of 43 175 individuals", Gut, 63, pp.530~532 (2014)
29. Aller R, "Consensus document. Management of nonalcoholic fatty liver disease (NAFLD). Clinical practice guideline", Gastroenterol Hepatol, 41, pp.328~349 (2018)
30. Sanyal AJ, "Endpoints and clinical trial design for nonalcoholic steatohepatitis", Hepatology, 54, pp.344~353 (2011)
31. Alcohol Research : Current Reviews Editorial Staff, "Drinking patterns and their definitions", Alcohol Res, 39, pp.17~18 (2018)
32. Bagnardi V, "Alcohol consumption and site-specific cancer risk : a comprehensive dose-response meta-analysis", Br J Cancer, 112, pp.580~593 (2015)
33. Cao Y, "Light to moderate intake of alcohol, drinking patterns, and risk of cancer : results from two prospective US cohort studies", BMJ, 351, pp.h4238~ (2015)
34. Wongtrakul W, "The effects of modest alcohol consumption on non-alcoholic fatty liver disease: a systematic review and meta-analysis", Front Med(Lausanne), 8, pp.744713~ (2021)
35. Rehm J, "Alcohol as a risk factor for liver cirrhosis : a systematic review and meta-analysis", Drug Alcohol Rev, 29, pp.437~445 (2010)
36. Corrao G, "Meta-analysis of alcohol intake in relation to risk of liver cirrhosis", Alcohol Alcohol, 33, pp.381~392 (1998)
37. Roerecke M, "Alcohol consumption and risk of liver cirrhosis : a systematic review and meta-analysis", Am J Gastroenterol, 114, pp.1574~1586 (2019)
38. Chang Y, "Nonheavy drinking and worsening of noninvasive fibrosis markers in nonalcoholic fatty liver disease : a cohort study", Hepatology, 69, pp.64~75 (2019)
39. Xu L, "Light-tomoderate alcohol consumption is associated with increased risk of type 2 diabetes in individuals with nonalcoholic fatty liver disease : a nine-year cohort study", Am J Gastroenterol, 115, pp.876~884 (2020)
40. Blomdahl J, "Moderate alcohol consumption is associated with advanced fibrosis in nonalcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus", Metabolism, 115, pp.154439~ (2021)
41. Ajmera V, "Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis", Clin Gastroenterol Hepatol, 16, pp.1511~1520 (2018)
42. Makiko Taniai, "Alcohol and hepatocarcinogenesis", Clinical and Molecular Hepatology, 26(4), pp.736~741 (2020), 대한간학회
43. Huang DQ, "Hepatocellular carcinoma incidence in alcohol-associated cirrhosis : systematic review and metaanalysis", Clin Gastroenterol Hepatol (2022)[DOI]
44. Turati F, "Alcohol and liver cancer : a systematic review and meta-analysis of prospective studies", Ann Oncol, 25, pp.1526~1535 (2014)
45. Heckley GA, "How the risk of liver cancer changes after alcohol cessation : a review and metaanalysis of the current literature", BMC Cancer, 11, pp.446~ (2011)
46. Savitz DA, "Can Cross-Sectional Studies Contribute to Causal Inference?", It Depends. Am J Epidemiol (2022)[DOI]
47. Livingston M, "Underreporting in alcohol surveys : whose drinking is underestimated?", J Stud Alcohol Drugs, 76, pp.158~164 (2015)
48. Rosoff DB, "Association of high-intensity binge drinking with lipid and liver function enzyme levels", JAMA Netw Open, 2, pp.e195844~ (2019)
49. Mitchell T, "Type and pattern of alcohol consumption is associated with liver fibrosis in patients with non-alcoholic fatty liver disease", Am J Gastroenterol, 113, pp.1484~1493 (2018)
50. Liu YT, "The effects of modest drinking on life expectancy and mortality risks : a populationbased cohort study", Sci Rep, 12, pp.7476~ (2022)
51. Kim BY, "Association between alcohol consumption status and obesity-related comorbidities in men : data from the 2016 Korean community health survey", BMC Public Health, 21, pp.733~ (2021)
52. Zhu L, "Characterization of gut microbiomes in nonalcoholic steatohepatitis(NASH)patients : a connection between endogenous alcohol and NASH", Hepatology, 57, pp.601~609 (2013)
53. Engstler AJ, "Insulin resistance alters hepatic ethanol metabolism : studies in mice and children with non-alcoholic fatty liver disease", Gut, 65, pp.1564~1571 (2016)
54. Yuan J, "Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae", Cell Metab, 30, pp.675~688 (2019)
55. Li NN, "High alcohol-producing Klebsiella pneumoniae causes fatty liver disease through 2, 3-butanediol fermentation pathway in vivo", Gut Microbes, 13, pp.1979883~ (2021)
56. "Alcohol and Public Health"[URL]
57. Dunn W, "Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease", Hepatology, 47, pp.1947~1954 (2008)
58. Rosenzweig T, "Red wine and wine pomace reduced the development of insulin resistance and liver steatosis in HFD-fed mice", J Funct Foods, 34, pp.379~389 (2017)
59. Marques C, "Impact of beer and nonalcoholic beer consumption on the gut microbiota : a randomized, double-blind, controlled trial", J Agric Food Chem, 70, pp.13062~13070 (2022)
60. Hernández-Quiroz F, "Influence of moderate beer consumption on human gut microbiota and its impact on fasting glucose and β-cell function", Alcohol, 85, pp.77~94 (2020)

관련 논문AI추천